Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Sberbank launches biometric payment across Russia
6/2/23
SBER
Etalon opened sales in a new project in St. Petersburg
6/2/23
ETLN
Broadcom announced a quarterly dividend
6/2/23
AVGO
Price placement of VTB shares will be β½0.018225
6/2/23
VTBR
Sitronics Group unveils double-deck electric catamaran
6/2/23
AFKS
GAZ may start producing cars under the Volga brand
6/2/23
GAZA
Sitronics Group will equip the Port of Sochi with the first Russian ship traffic control system
6/2/23
AFKS
Broadcom reported for 6 months of fiscal year 2023
6/2/23
AVGO
Sitronics Group plans to build a hydrogen-powered ship by the end of summer
6/2/23
AFKS
Sollers expects to increase sales by 12% in 2023
6/1/23
SVAV
«
Previous
596
597
598
599
600
601
602
603
604
605
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)